CIDP (chronic inflammatory demyelinating polyneuropathy): open trials in Argentina

• NCT05327114

  Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

  Trial Treatment · Phase 2/3 · Janssen Research & Development, LLC

  Instituto Fleni, Buenos Aires · Hospital Gral Agudos Ignacio Pirovano, Buenos Aires · Hospital Italiano de Buenos Aires, Buenos Aires · INECO Neurociencias Oroño, Rosario

  Registry updated 2026-11-03

• NCT06920004

  A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP

  Trial Treatment · Phase 3 · argenx

  Instituto Privado Kremer, Córdoba · INECO Neurociencias Oroño, Rosario

  Registry updated 2026-11-03

• NCT06858579

  A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)

  Trial Treatment · Phase 3 · Dianthus Therapeutics

  Clinical Study Site #2, Buenos Aires · Cinical Study Site #3, Buenos Aires · Cinical Study Site, Buenos Aires · Clinical Study Site, Buenos Aires · Cinical Study Site #4, Buenos Aires · Cinical Study Site, Rosario · Clinical Study Site, San Miguel de Tucumán · Cinical Study Site #2, San Miguel de Tucumán

  Registry updated 2026-10-28

• NCT06859099

  Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP

  Trial Treatment · Phase 3 · Sanofi

  Investigational Site Number : 0320003, Buenos Aires

  Registry updated 2026-10-27

• NCT07091630

  A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP

  Trial Treatment · Phase 3 · argenx

  Instituto Privado Kremer, Córdoba · INECO Neurociencias Oroño, Rosario · Instituto Médico de la Fundación Estudios Clínicos, Rosario

  Registry updated 2026-10-27

• NCT06290141

  A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

  Trial Treatment · Phase 3 · Sanofi

  Investigational Site Number : 0320001, Buenos Aires · Investigational Site Number : 0320003, Buenos Aires · Investigational Site Number : 0320002, Buenos Aires

  Registry updated 2026-10-19

• NCT07032662

  Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

  Trial Treatment · Phase 2 · Immunovant Sciences GmbH

  Site Number - 5006, Buenos Aires · Site Number - 5002, Buenos Aires · Site Number - 5003, Córdoba · Site Number - 5001, Córdoba · Site Number - 5005, Rosario · Site Number - 5000, Rosario

  Registry updated 2026-09-30

All CIDP (chronic inflammatory demyelinating polyneuropathy) trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error